Lixisenatide Subcutaneous and Morphine ER
Determining the interaction of Lixisenatide Subcutaneous and Morphine ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Morphine Extended-Release Capsules
- Lixisenatide Subcutaneous-Morphine Immediate-Release Tablets and Capsules
- Lixisenatide Subcutaneous-Morphine injection
- Lixisenatide Subcutaneous-Morphine Injection PF
- Lixisenatide Subcutaneous-Morphine Long-Acting Tablets
- Lixisenatide Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Morphine ER-Lixtraxen Injection
- Morphine ER-LMD
- Morphine ER-LMD Injection
- Morphine ER-LMX 4 Topical application
- Morphine ER-LMX 5
- Morphine ER-LMX 5 Topical application